NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 412 filers reported holding NOVAVAX INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,157 | +53.6% | 56,099 | +57.6% | 0.00% | 0.0% |
| Q2 2023 | $264,508 | -2.9% | 35,600 | -9.4% | 0.00% | 0.0% |
| Q1 2023 | $272,391 | -93.0% | 39,306 | -81.7% | 0.00% | -94.4% |
| Q3 2022 | $3,908,000 | -16.7% | 214,722 | +135.4% | 0.02% | -10.0% |
| Q2 2022 | $4,691,000 | +1112.1% | 91,220 | +1639.2% | 0.02% | +1900.0% |
| Q1 2022 | $387,000 | -95.1% | 5,245 | -90.6% | 0.00% | -96.2% |
| Q4 2021 | $7,946,000 | -11.0% | 55,543 | +28.9% | 0.03% | -16.1% |
| Q3 2021 | $8,929,000 | +1541.4% | 43,074 | +1338.7% | 0.03% | +1450.0% |
| Q1 2021 | $544,000 | -65.6% | 2,994 | -78.9% | 0.00% | -71.4% |
| Q4 2020 | $1,583,000 | +65.8% | 14,197 | +60.9% | 0.01% | +75.0% |
| Q3 2020 | $955,000 | -91.1% | 8,823 | -93.2% | 0.00% | -92.6% |
| Q2 2020 | $10,767,000 | – | 129,184 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |